Skip to content

SARODENT

Active Private limited companyfounded 2000active for 26 yearsRue Entre-deux-Villes 7, 4670 BlegnyKBO/BCE: BE 0472.040.008

Lifetime

20 annual accounts with figures on one time axis, 26 filings since 2000
peak of €831,145 in 2025
€831,145▲ 14.0%
lowest -€22,872 in 2015
€150,109▲ 27.3%
peak of €272,303 in 2023
€140,339▲ 55.5%
€233,905▼ 26.3%
peak of 9 FTE in 2024
9 FTEunchanged
Board1 name since 2021
1 director
Documentsfilings and deeds
22-09-202653 days late
2025abbreviated format
Gross margin from €729,147 to €831,145Result from €117,927 to €150,109Dividend €100,000Equity from €90,229 to €140,339Debts from €317,516 to €233,905Cash from €9,729 to €43,524

Key points

from the 2025 annual accounts

Equity

€140,339 from €272,303 in 2023

Equity fell by 48% in 2 years.

Securities

€77,627

Pledge on other assets, new in 2025. 55.3% of equity · not in the 2024 accounts.

Filings

26 annual accounts since 2000
AprilJune31 JulyOctober200020102020

Five of the last ten came late. The 2024 accounts came in latest, 61 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as SARODENT has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,389 companies, not a prediction for SARODENT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0472040008
reappointed as sole director Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 07-12-2023 · Gazette deed
First establishment Rue Entre-deux-Villes 5/7, Blegny
All 39 events

Comparable companies

same main activity, similar in size and age
Company
SARODENT Blegny €374,244 €831,145 37.5% 9
Solutions Ortho Herve €394,140 €576,730 57.7% 7.5
PROTHESIA NV DENTAAL BEDRIJF Wijnegem €413,587 €372,375 26.6% 6.6
Laboratoire de Prothèse dentaire Jardon Liège €447,414 €639,241 36.7% 9.6
Laboratoire Dentaire PIRNAY BALDACCHINO Liège €411,079 €525,175 -2.5% 8.7
PROVIDENS Wanze €735,866 €353,952 60.1% 6
OPTIC BARCHON Blegny €588,654 €548,768 44.2% 5.3

These companies have the same main activity as SARODENT: manufacture of medical and dental instruments and supplies (NACE 32500). They are comparable in size and age: total assets between €394,000 and €736,000, founded between 1978 and 2013.

Official details

Source: KBO
Status
Active since 02-06-2000Normal situation
Activity
Manufacture of medical and dental instruments and suppliesNACE 32500
Establishment unit
2.182.001.5384670 Blegny, since 29-06-2000
Financial year end
31 December
Peppol
Reachable since 08-12-2025
Company details

Annual accounts 2025

≈ €2.0mestimated
€374,244▼ 8.2%
Filing
Filed on 22-09-2026
Financials

Insights on SARODENT

SARODENT files the abbreviated format. That format states no turnover. The gross margin rose from €158,638 in 2006 to €831,145 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about SARODENT

What is the company number of SARODENT?
The company number of SARODENT is 0472.040.008. The VAT number is the same number with BE in front: BE 0472.040.008.
Where is SARODENT based?
The registered office is at Rue Entre-deux-Villes 7, 4670 Blegny.Company details
What does SARODENT do?
According to the KBO register, the main activity is manufacture of medical and dental instruments and supplies (NACE 32500).
What is the legal form of SARODENT?
SARODENT is a private limited company (BV).
When was SARODENT founded?
SARODENT was founded on 02-06-2000.
Is SARODENT still active?
Yes, SARODENT is an active enterprise in the KBO register.
How many employees does SARODENT have?
SARODENT had an average of 9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of SARODENT?
The turnover in financial year 2025 is ≈ €2.0m. This figure is estimated from the gross margin of €831,145 and 2,136 comparable companies of the same size. It probably lies between €1.2m and €3.4m. It is a rough estimate.
Is SARODENT profitable?
In financial year 2025, SARODENT made a profit of €150,109.
Where can I find the annual accounts of SARODENT?
SARODENT filed 26 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SARODENT due?
SARODENT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.